Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, announced today...

Related Keywords

California ,United States ,San Diego ,India ,Australia ,Dallas ,Texas ,New York ,Samuel Barone ,Psulagna Bhattacharya ,Office Of Cellular ,Prnewswire Nanoscope Therapeutics Inc ,University Of California ,Clinical Development ,Nanoscope Therapeutics Inc ,United States Air ,Pennsylvania State University College Of Medicine ,Office Of Therapeutic Products ,Drug Administration ,Therapeutics Inc ,Chief Medical ,Chief Executive Officer ,Chief Medical Officer ,Gemini Therapeutics ,Disc Medicine ,Veloce Biopharma ,Avalanche Biotechnologies ,Senior Vice President ,Senior Medical Officer ,Gene Therapies ,Therapeutic Products ,Pennsylvania State University College ,New York Eye ,Ear Infirmary ,Nanoscope Therapeutics ,